3 Warning Signs for Cannabis Investors

Is now the time to buy Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ)? Here are three headwinds that may make you reconsider.

Boy, what a year 2019 was for investors in Canada’s new cannabis industry. The mood among many has certainly shifted, and the euphoria with which companies were gobbling each other up has abated. Horizons Marijuana Life Sciences Index ETF is now down 65% from its 52-week high in early 2019 (not its overall peak).

Questions about where the bottom is remain, and with cannabis stocks continuing to slide with seemingly no end in sight, investors remain cautious with respect to these names, and deservedly so.

Here are three of the biggest question marks, or warning signs, if you will, that investors need to keep an eye on in 2019 when considering if/when to jump back into the fray.

Inventory levels

I’ve pointed to this in the past — there’s a glut of inventory out there, and it’s killing margins. Companies are being forced to destroy product; cannabis is a natural product, and has a shelf life. It’s also a commodity, and supply and demand is a real thing that drives prices.

With provincial distributors the main customers of most cannabis producers, the “price taker” reality for producers is starting to kick in (and it appears investors are starting to notice this issue).

As of mid-2019, the glut was approximated at 150,000 kg of the green stuff — a truly staggering sum.

Black market is alive and strong

The black market is unregulated.

This fact alone is enough to make anyone understand the disadvantage any large-scale licensed cannabis producer has when competing against some guys growing plants in their basement. I’ve gone into detail about a few of the key hurdles producers face and given readers a taste of some of the red tape cannabis producers have to fight through to get their product to market.

You can bet the Canadian government will want to take bigger and bigger tax bites out of the profit pie that producers are able to consume most of right now. As margins shrink and taxes rise, expect to see profit expectations continue to drop, hurting share prices further. I still do not believe the true impact of future taxation and over-regulation are built into these producers’ share prices.

Cannabis retail is failing consumers

Having cannabis packaged in a similar fashion to cigarettes is killing the retail experience. Having product at government stores locked behind an opaque cabinet, with consumers having to guess what they are going to get, is mind boggling.

The retail experience at most government stores across the country is lacking. The guy on the street corner has the advantage at this stage in the game, and while the government talks a big talk about getting rid of the black market across the country, the abysmal way in which cannabis is retailed at this point in time is likely to lead to continued problems with black market penetration in 2020 and beyond.

Ontario has realized this issue, and there are seemingly plans to privatize retail in that province; questions remain, however, as to what regulations will be put in place for these retailers (if they’re held to the same standards as government stores, it won’t help). The one hope for cannabis investors is that private stores will roll out quicker, as this has been another major pain point for the industry — the true lack of physical retail locations, again, due mostly to government regulation.

Stay Foolish, my friends.

Fool contributor Chris MacDonald has no position in any stocks mentioned in this article.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »